Estrogen suppresses brain mitochondrial oxidative stress in female and male rats

Brain Research

Volumn 1176, Issue 1, 2007, Pages 71-81

  Razmara, Ali ^a   Duckles, Sue P ^a   Krause, Diana N ^a   Procaccio, Vincent ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endocrine; Estrogen; Mitochondria; Neuroprotection; Oxidation; Testosterone

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ESTRADIOL; ESTROGEN; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; SEX HORMONE; TESTOSTERONE;

ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GONADECTOMY; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ACONITATE HYDRATASE; ANIMALS; BRAIN; CYTOPROTECTION; DOWN-REGULATION; ENERGY METABOLISM; ESTROGENS; FEMALE; GONADS; MALE; MITOCHONDRIA; OXIDATIVE STRESS; PC12 CELLS; RATS; RATS, INBRED F344; REACTIVE OXYGEN SPECIES; SEX CHARACTERISTICS; SUPEROXIDE DISMUTASE;

ANIMALIA; RATTUS;

EID: 35148853175     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.08.036     Document Type: Article

References (70)

1. Aliev G., et al. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol. 12 (2002) 21-35
2. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 10 (2004) S18-S25 (Suppl)
3. Azevedo R.B., et al. Regulation of antioxidant enzyme activities in male and female rat macrophages by sex steroids. Braz. J. Med. Biol. Res. 34 (2001) 683-687
4. Beal M.F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58 (2005) 495-505
5. Beckman K.B., and Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78 (1998) 547-581
6. Behl C., et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51 (1997) 535-541
7. Beyer R.E. An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. Biochem. Cell Biol. 70 (1992) 390-403
8. Borras C., et al. Mitondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol. Med. 34 (2003) 546-552
9. Bulun S.E., et al. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J. Steroid. Biochem. Mol. Biol. 86 (2003) 219-224
10. Cadenas E., and Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29 (2000) 222-230
11. Calabrese V., et al. Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res. 26 (2001) 739-764
12. Cannon B., et al. Uncoupling proteins: a role in protection against reactive oxygen species- or not?. Biochim. Biophys. Acta 1757 (2006) 449-458
13. Casteilla L., et al. Mitochondrial ROS metabolism: modulation by uncoupling proteins. IUBMB Life. 52 (2001) 181-188
14. Castellani R., et al. Role of mitochondrial dysfunction in Alzheimer's disease. J. Neurosci. Res. 70 (2002) 357-360
15. Chan S.L., et al. Mitochondrial uncoupling protein-4 regulates calcium homeostasis and sensitivity to store depletion-induced apoptosis in neural cells. J. Biol. Chem. 281 (2006) 37391-37403
16. Chance B., et al. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979) 527-605
17. Clayton D.A. Transcription of the mammalian mitochondrial genome. Ann. Rev. Biochem. 53 (1984) 573-594
18. Duckles S.P., et al. Estrogen and mitochondria: a new paradigm for vascular protection?. Mol. Interv. 6 (2006) 26-35
19. Dykens J.A. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: implications for neurodegeneration. J. Neurochem. 63 (1994) 584-591
20. Erlanson-Albertsson C. The role of uncoupling proteins in the regulation of metabolism. Acta Physiol. Scand. 178 (2003) 405-412
21. Fujimoto R., et al. Androgen receptors, 5 alpha-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells. J. Steroid. Biochem. Mol. Biol. 50 (1994) 169-174
22. Gardner P.R., and Fridovich I. Superoxide sensitivity of the Escherichia coli aconitase. J. Biol. Chem. 266 (1991) 19328-19333
23. Gardner P.R., and Fridovich I. Inactivation-reactivation of aconitase in Escherichia coli. A sensitive measure of superoxide radical. J. Biol. Chem. 267 (1992) 8757-8763
24. Gardner P.R., et al. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12248-12252
25. Geary G.G., et al. Gonadal hormones affect diameter of male rat cerebral arteries through endothelium-dependent mechanisms. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H610-H618
26. Gonzales R.J., et al. Androgenic/estrogenic balance in the male rat cerebral circulation: metabolic enzymes and sex steroid receptors. J. Cereb. Blood Flow. Metab. (2007)
27. Gonzales R.J., et al. Testosterone treatment increases thromboxane function in rat cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H578-H585
28. Green P.S., and Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18 (2000) 347-358
29. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 2424-2428
30. Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann. N.Y. Acad. Sci. 1067 (2006) 10-21
31. Hausladen A., and Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 269 (1994) 29405-29408
32. Henderson V.W. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 138 (2006) 1031-1039
33. Hess R.A., et al. A role for oestrogens in the male reproductive system. Nature 390 (1997) 509-512
34. Ho P.W., et al. Knockdown of uncoupling protein-5 in neuronal SH-SY5Y cells: effects on MPP+-induced mitochondrial membrane depolarization, ATP deficiency, and oxidative cytotoxicity. J. Neurosci. Res. 84 (2006) 1358-1366
35. Jones M.E., and Simpson E.R. Oestrogens in male reproduction. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 14 (2000) 505-516
36. Keller J.N., et al. 17Beta-estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid beta-peptide and iron. J. Neurosci. Res. 50 (1997) 522-530
37. Keller J.N., et al. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18 (1998) 687-697
38. Kennedy M.C., et al. The role of iron in the activation-inactivation of aconitase. J. Biol. Chem. 258 (1983) 11098-11105
39. Kokoszka J.E., et al. Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2278-2283
40. Krebs H.A., and Holzach O. The conversion of citrate into cis-aconitate and isocitrate in the presence of aconitase. Biochem. J. 52 (1952) 527-528
41. Liu P.Y., et al. Androgens and cardiovascular disease. Endocr. Rev. 24 (2003) 313-340
42. MacMillan-Crow L.A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 11853-11858
43. Marklund S. Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids. Acta Physiol. Scand Suppl. 492 (1980) 19-23
44. Mattiasson G., et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med. 9 (2003) 1062-1068
45. McNeill A.M., et al. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30 (1999) 2186-2190
46. Murakoshi M., et al. Regulation of prostatic glutathione-peroxidase (GSH-PO) in rats treated with a combination of testosterone and 17 beta-estradiol. J. Toxicol. Sci. 24 (1999) 415-420
47. Nilsen J., and Diaz Brinton R. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2842-2847
48. Nilsen J., and Brinton R.D. Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr. Drug Targets CNS Neurol. Disord. 3 (2004) 297-313
49. Nilsen J., et al. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci. 7 (2006) 74
50. Patel M., et al. Requirement for superoxide in excitotoxic cell death. Neuron. 16 (1996) 345-355
51. Pedram A., et al. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol. Biol. Cell 17 (2006) 2125-2137
52. Prokai L., et al. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11741-11746
53. Racker E. Spectrophotometric measurements of the enzymatic formation of fumaric and cis-aconitic acids. Biochim. Biophys. Acta 4 (1950) 211-214
54. Razmara A., et al. Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats. Am J Physiol. Heart Circ. Physiol. 289 (2005) H1843-H1850
55. Reisert I., and Pilgrim C. Sexual differentiation of monoaminergic neurons-genetic or epigenetic?. Trends Neurosci. 14 (1991) 468-473
56. Robinson K.M., et al. Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15038-15043
57. Rousset S., et al. The biology of mitochondrial uncoupling proteins. Diabetes 53 Suppl 1 (2004) S130-S135
58. Simpson E., et al. The role of local estrogen biosynthesis in males and females. Trends Endocrinol. Metab. 11 (2000) 184-188
59. Singh M., et al. Novel mechanisms for estrogen-induced neuroprotection. Exp. Biol. Med. (Maywood). 231 (2006) 514-521
60. St-Pierre J., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127 (2006) 397-408
61. Stirone C., et al. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol. Pharmacol. 68 (2005) 959-965
62. Strehlow K., et al. Modulation of antioxidant enzyme expression and function by estrogen. Circ. Res. 93 (2003) 170-177
63. Szewczyk A., and Wojtczak L. Mitochondria as a pharmacological target. Pharmacol. Rev. 54 (2002) 101-127
64. Tong J.J., et al. Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster. Nat Genet. 39 (2007) 476-485
65. Turrens J.F. Mitochondrial formation of reactive oxygen species. J Physiol. 552 (2003) 335-344
66. Vina J., et al. Mitochondrial theory of aging: importance to explain why females live longer than males. Antioxid. Redox Signal. 5 (2003) 549-556
67. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39 (2005) 359-407
68. Williams M.D., et al. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol. Chem. 273 (1998) 28510-28515
69. Wise P.M. Estrogens and neuroprotection. Trends Endocrinol. Metab. 13 (2002) 229-230
70. Yang S.H. Estrogens as protectants of the neurovascular unit against ischemic stroke. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 169-177